Gene · 4176
Papers3,001
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 3,001
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Huaier Suppresses the Hepatocellular Carcinoma Cell Cycle by Regulating Minichromosome Maintenance Proteins. | Onco Targets Ther | 2020 | 33244243 | PubTator, text mining | PubMed |
| The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation. | Nat Commun | 2020 | 33239621 | PubTator, text mining | PubMed |
| The deubiquitinase USP36 Regulates DNA replication stress and confers therapeutic resistance through PrimPol stabilization. | Nucleic Acids Res | 2020 | 33237263 | PubTator, text mining | PubMed |
| Bioinformatics Analysis Identifies a Novel Role of GINS1 Gene in Colorectal Cancer. | Cancer Manag Res | 2020 | 33235499 | PubTator, text mining | PubMed |
| Integrative p53, micro-RNA and Cathepsin Protease Co-Regulatory Expression Networks in Cancer. | Cancers (Basel) | 2020 | 33233599 | PubTator, text mining | PubMed |
| Bioinformatics analysis of multi-omics data identifying molecular biomarker candidates and epigenetically regulatory targets associated with retinoblastoma. | Medicine (Baltimore) | 2020 | 33217867 | PubTator, text mining | PubMed |
| MicroRNA-Based Fingerprinting of Cervical Lesions and Cancer. | J Clin Med | 2020 | 33203149 | PubTator, text mining | PubMed |
| Development of cancer prognostic signature based on pan-cancer proteomics. | Bioengineered | 2020 | 33200655 | PubTator, text mining | PubMed |
| Apigenin as Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer. | Front Chem | 2020 | 33195038 | PubTator, text mining | PubMed |
| The Enigmatic Thelebolaceae (Thelebolales, Leotiomycetes): One New Genus Solomyces and Five New Species. | Front Microbiol | 2020 | 33193172 | PubTator, text mining | PubMed |
| Expression Profile of GINS Complex Predicts the Prognosis of Pancreatic Cancer Patients. | Onco Targets Ther | 2020 | 33192076 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Expression and Prognosis for MCMs in Human Gastric Cancer. | Technol Cancer Res Treat | 2020 | 33167799 | PubTator, text mining | PubMed |
| Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. | Cells | 2020 | 33167477 | PubTator, text mining | PubMed |
| Identification of mini-chromosome maintenance 8 as a potential prognostic marker and its effects on proliferation and apoptosis in gastric cancer. | J Cell Mol Med | 2020 | 33155430 | PubTator, text mining | PubMed |
| Comparison of TMA Technique and Routine Whole Slide Analysis in Evaluation of Proliferative Markers Expression in Laryngeal Squamous Cell Cancer. | In Vivo | 2020 | 33144432 | PubTator, text mining | PubMed |
| An integrative multi-omics network-based approach identifies key regulators for breast cancer. | Comput Struct Biotechnol J | 2020 | 33133424 | PubTator, text mining | PubMed |
| Usefulness of serum miR-1246/miR-106b ratio in patients with esophageal squamous cell carcinoma. | Oncol Lett | 2020 | 33123261 | PubTator, text mining | PubMed |
| MCM10 Acts as a Potential Prognostic Biomarker and Promotes Cell Proliferation in Hepatocellular Carcinoma: Integrated Bioinformatics Analysis and Experimental Validation. | Cancer Manag Res | 2020 | 33116820 | PubTator, text mining | PubMed |
| Analysis of Differential Expression Proteins of Paclitaxel-Treated Lung Adenocarcinoma Cell A549 Using Tandem Mass Tag-Based Quantitative Proteomics. | Onco Targets Ther | 2020 | 33116610 | PubTator, text mining | PubMed |
| A new species concept for the clinically relevant Mucor circinelloides complex. | Persoonia | 2020 | 33116336 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4176/papers?page=45